Antimyeloma activity of heat shock protein-90 inhibition

We show that multiple myeloma (MM), the second most commonly diagnosed hematologic malignancy, is responsive to hsp90 inhibitors in vitro and in a clinically relevant orthotopic in vivo model, even though this disease does not depend on HER2/neu, bcr/abl, androgen or estrogen receptors, or other hsp...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Mitsiades, Constantine S., Mitsiades, Nicholas S., McMullan, Ciaran J., Poulaki, Vassiliki, Kung, Andrew L., Davies, Faith E., Morgan, Gareth, Akiyama, Masaharu, Shringarpure, Reshma, Munshi, Nikhil C., Richardson, Paul G., Hideshima, Teru, Chauhan, Dharminder, Gu, Xuesong, Bailey, Charles, Joseph, Marie, Libermann, Towia A., Rosen, Neal S., Anderson, Kenneth C.
Format: Artigo
Jezik:Inglês
Izdano: © 2006 by The American Society of Hematology 2006
Teme:
Neoplasia
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC1895907/
https://ncbi.nlm.nih.gov/pubmed/16234364
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2005-03-1158
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki